Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.350
-0.130 (-5.25%)
May 7, 2026, 12:42 PM EDT - Market open
Connect Biopharma Holdings Employees
Connect Biopharma Holdings had 64 employees as of December 31, 2025. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$1,000
Profits / Employee
-$866,875
Market Cap
132.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 64 | 2 | 3.23% |
| Dec 31, 2024 | 62 | -19 | -23.46% |
| Dec 31, 2023 | 81 | -19 | -19.00% |
| Dec 31, 2022 | 100 | -8 | -7.41% |
| Jan 1, 2022 | 108 | 46 | 74.19% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Alps Group | 93 |
| Immunic | 92 |
| InflaRx | 65 |
| Equillium | 35 |
| Spero Therapeutics | 25 |
| TuHURA Biosciences | 22 |
| Edesa Biotech | 17 |
CNTB News
- 14 days ago - Connect Biopharma announces enrollment in Seabreeze STAT study - TheFly
- 14 days ago - Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis - GlobeNewsWire
- 5 weeks ago - Connect Biopharma director buys $4.0M in common stock - TheFly
- 5 weeks ago - Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Connect Biopharma Holdings Transcript: Study result - Transcripts
- 5 weeks ago - Connect Biopharma announces results from rademikibart study - TheFly
- 5 weeks ago - Connect Biopharma Announces $20.2 Million Private Placement Financing - GlobeNewsWire
- 5 weeks ago - Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study - GlobeNewsWire